Septerna Revenue

In the year 2025, Septerna had annual revenue of $45.95M with 4,174.51% growth. Septerna had revenue of $24.12M in the quarter ending December 31, 2025, with 11,276.42% growth.

Revenue (ttm)

$45.95M

Revenue Growth

+4,174.51%

P/S Ratio

25.21

Revenue / Employee

$353,469

Employees

130

Market Cap

1.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	45.95M	44.88M	4,174.51%
Dec 31, 2024	1.08M	924.00K	611.92%
Dec 31, 2023	151.00K	-	-
Dec 31, 2022	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SEPN News

8 days ago - Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism - GlobeNewsWire
6 weeks ago - Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
7 weeks ago - Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy - GlobeNewsWire
2 months ago - Septerna to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
2 months ago - Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
2 months ago - Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting - GlobeNewsWire
3 months ago - Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer - GlobeNewsWire
4 months ago - Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire

More News